By Michael Solomon, Ph.D., MBA This is the second of a three-part series on AI applications to support prescription drug prescribing and therapy Amidst the uncertainty of healthcare policy and …
By Michael Solomon, PhD, MBA, Practice Lead, eCare Management With billions of dollars flowing into artificial intelligence (AI) technology for healthcare, it’s no surprise that AI is rising to the …
By Michael Solomon, PhD, MBA, Practice Lead, eCare Management The unprecedented restructuring of the U.S. payer market continues, with three more announcements of payers moving to vertically integrate with pharmacy …
By Michael Solomon, PhD, MBA Big moves by market-leading commercial payers signal sweeping transformative change is underway for health insurers and pharmacy benefit managers (PBMs). This change has the potential …
Insights for Life Sciences Companies As the quality of payers’ data on their members’ health outcomes gets better with each passing day, achieving measurable quality targets is increasingly becoming the basis for …
Investing in population health management programs (PHMs) is becoming increasingly important for pharmaceutical manufacturers. Amidst the uncertainty of health reform, we can still count on payers pushing ahead in their efforts to contract with …
By Michael Solomon Whenever I engage in discussion with health care executives or clinicians about strategies and programs for population health management (PHM), we have to step back and invest …
By Michael Solomon, PhD, MBA, Practice Lead, eCare Management Everyone is talking about ways to engage patients in their healthcare. Payers, providers, pharmaceutical manufacturers, and HIT vendors are making major investments …